Home
Blog
Features
Sign Up
Try the Demo today!
Home
Market
Reports
Search
Alerts
Ticker
Company Name
Insider Name
Insider Trading Guide
About
Contact Us
Login
Tubridy Karen L
Insider Overview
Current Sentiment
Insider Transactions
Email this page »
Avg. Two Year Performance
No purchase track record
19%
Avg. Sale Return
9%
Compound
1 Mo
3 Mo
6 Mo
1 Yr
2 Yr
Average Purchase Return
--
--
--
--
--
Purchase Success Rate
--
--
--
--
--
Average Sale Return
16%
(6%)
(< 1%)
15%
19%
Sale Success Rate
2 of 3
1 of 3
2 of 3
2 of 3
2 of 3
Carisma Therapeutics Inc.
Drugs
» Biotechnology
Chief Development Officer:
Holdings:
32.75K
shares
Sentiment
Avg. Two Year Performance
No purchase track record
No sale track record
Last Three Months:
0
Net Amount
Buy:
0
--
Sell:
0
--
Akebia Therapeutics, Inc.
Drugs
» Biotechnology
SVP, Chief Development Officer:
Holdings:
84.68K
shares
Sentiment
Avg. Two Year Performance
No purchase track record
No sale track record
Last Three Months:
0
Net Amount
Buy:
0
--
Sell:
0
--